Showing results (11-20 of 14) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Cancer Cell|February 5, 2010
Preexistence and clonal selection of MET amplification in EGFR mutant NSCLCAlexa B Turke, Kreshnik Zejnullahu, Yi-Long Wu, et al.Cancer Research|December 20, 2007
PF00299804, an irreversible pan-ERBB inhibitor, is effective in lung cancer models with EGFR and ERBB2 mutations that are resistant to gefitinibJeffrey A Engelman, Kreshnik Zejnullahu, Christopher-Michael Gale, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2008
EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancerJussi P Koivunen, Craig Mermel, Kreshnik Zejnullahu, et al.Science Translational Medicine|September 9, 2011
Activation of ERBB2 signaling causes resistance to the EGFR-directed therapeutic antibody cetuximabKimio Yonesaka, Kreshnik Zejnullahu, Isamu Okamoto, et al.Pageof 2